Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Researchers from Hebrew University publish findings in immunization
July 30th, 2008
Scientists discuss in 'DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis' new findings in immunization. According to recent research from Jerusalem, Israel, "We have shown recently that cDNA vaccination, using a virtual lymph node, ameliorates experimental allergic encephalomyelitis. Successful cure from mammary tumor requires resolution of local tumor growth and metastases." "We have examined whether targeting of CD44 cell surface adhesion molecule by cDNA vaccination plays a role in resolving mammary tumor development. We show here that CD44 cDNA vaccination decreases the tumor mass and metastatic potential in...
Source: Vaccine Weekly (2008-07-30)
|
